Botanix Pharmaceuticals Ltd
BOT•Health Care•Biotechnology•Last updated: Dec 25
About
Botanix Pharmaceuticals Ltd is a clinical stage synthetic cannabinoid pharmaceutical company. The company focuses on developing treatments for dermatological and antimicrobial conditions. Its main segments include dermatology, where it develops products for skin diseases such as acne and atopic dermatitis, and antimicrobial, focusing on treatments for serious infections. Botanix utilizes its proprietary Permetrex drug delivery technology to enhance the delivery of active pharmaceutical ingredients.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- BOT
Related Shares
Investor Resources
Should you buy Botanix Pharmaceuticals Ltd right now?
While BOT looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now